ProfileGDS4718 / 208424_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 87% 81% 83% 83% 84% 90% 92% 87% 79% 85% 86% 83% 88% 87% 89% 84% 86% 90% 93% 88% 85% 85% 85% 86% 84% 91% 84% 88% 83% 88% 90% 89% 83% 87% 89% 93% 80% 87% 85% 82% 87% 92% 89% 87% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.7624887
GSM549102patient 115, normal, homogenized [OPG study]7.9229781
GSM549104patient 119, normal, homogenized [OPG study]8.2880583
GSM549108patient 138, normal, homogenized [OPG study]8.1312783
GSM549119patient 077, normal, homogenized [OPG study]8.2484284
GSM549133patient 032, cancer, homogenized [OPG study]9.3042490
GSM549139patient 042, cancer, homogenized [OPG study]9.5348292
GSM549099patient 107, normal, homogenized [OPG study]8.6505187
GSM549109patient 139, normal, homogenized [OPG study]7.7061979
GSM549110patient 046, normal, homogenized [OPG study]8.4322285
GSM549114patient 063, normal, homogenized [OPG study]8.7174386
GSM549122patient 082, normal, homogenized [OPG study]8.1859583
GSM549134patient 033, cancer, homogenized [OPG study]8.9543188
GSM549136patient 036, cancer, homogenized [OPG study]8.7896287
GSM549140patient 044, cancer, homogenized [OPG study]9.0492689
GSM549111patient 047, normal, homogenized [OPG study]8.4483684
GSM549113patient 057, normal, homogenized [OPG study]8.7003786
GSM549132patient 031, cancer, homogenized [OPG study]9.2112490
GSM549137patient 038, cancer, homogenized [OPG study]9.6219193
GSM549142patient 047, cancer, homogenized [OPG study]8.4035388
GSM549100patient 110, normal, homogenized [OPG study]8.4282185
GSM549107patient 135, normal, homogenized [OPG study]8.5410785
GSM549115patient 068, normal, homogenized [OPG study]8.5985385
GSM549116patient 072, normal, homogenized [OPG study]8.71786
GSM549120patient 078, normal, homogenized [OPG study]8.3158284
GSM549131patient 030, cancer, homogenized [OPG study]9.4703891
GSM549118patient 074, normal, homogenized [OPG study]8.3894284
GSM549129patient 027, cancer, homogenized [OPG study]8.7388188
GSM549123patient 088, normal, homogenized [OPG study]8.2560283
GSM549124patient 006, cancer, homogenized [OPG study]8.7933988
GSM549126patient 015, cancer, homogenized [OPG study]9.1901890
GSM549128patient 025, cancer, homogenized [OPG study]8.9842189
GSM549103patient 117, normal, homogenized [OPG study]8.0682483
GSM549117patient 073, normal, homogenized [OPG study]8.9019487
GSM549138patient 041, cancer, homogenized [OPG study]9.004789
GSM549141patient 045, cancer, homogenized [OPG study]9.8285893
GSM549130patient 028, cancer, homogenized [OPG study]7.8411180
GSM549101patient 111, normal, homogenized [OPG study]8.6545587
GSM549105patient 128, normal, homogenized [OPG study]8.3696985
GSM549106patient 134, normal, homogenized [OPG study]8.2567382
GSM549112patient 048, normal, homogenized [OPG study]8.7652787
GSM549125patient 011, cancer, homogenized [OPG study]9.478392
GSM549127patient 024, cancer, homogenized [OPG study]9.0133289
GSM549135patient 035, cancer, homogenized [OPG study]8.8094987